Navigation Links
Inverness Medical Innovations Announces Fourth Quarter 2008 Results
Date:2/18/2009

="_new">www.invernessmedical.com/News.cfm) two hours after the end of the call and will be accessible for 30 days. Additionally, reconciliations to non-GAAP financial measures not included in this press release that may be discussed during the call will also be available at the same website beginning shortly before the conference call and will continue to be available on this website for 30 days.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life at home. Inverness' global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

               Inverness Medical Innovations, Inc. and Subsidiaries
               Condensed Consolidated Statements of Operations and
              Reconciliation to Non-GAAP Adjusted Cash Basis Amounts
                       (in $000s, except per share amounts)


                                      Year Ended December 31, 2008
                                      ----------------------------
                                                                 Non-GAAP
                                                                 Adjusted
                                           Non-GAAP                Cash
                               GAAP      Adjustments             Basis (a)
                               ----      -----------             ---------

    Net product sales and
     services revenue       $1,645,600         $-               $1,645
'/>"/>
SOURCE  Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 

Related medicine news :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results
2. James Roosevelt, Jr. Joins Inverness Medical Innovations Board of Directors
3. Inverness Medical Innovations to Present at the 2009 UBS Global Healthcare Services Conference on February 10, 2009
4. Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008
5. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
6. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
7. Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
8. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
9. Inverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008
10. Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
11. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay ... life, but some of the changes brought about by ... diabetes. New research has found that people with ... percent higher risk of having a severe low blood ... compared to people with diabetes who aren,t depressed. ...
(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...
(Date:5/21/2013)... The team at Comfort &Harmony™, a leader in nurturing ... a nursing pillow. , Nursing pillows are designed ... , In a nursing pillow, important things to ... Designers at Comfort & Harmony, kept this list in mind ... pillow needs to fit a mom’s body and feel comfortable. ...
(Date:5/21/2013)... Texas (PRWEB) May 21, 2013 ... and process automation applications for video collaboration, today ... innovative vRating index evaluates key performance metrics related ... have an immediate, aggregated indicator of the performance ... of the Vyopta vAnalytics™ application, the vRating™ delivers ...
(Date:5/21/2013)... MAY 21, 2013 Three major Ohio universities and ... Foundation to establish a new collaborative research program aimed ... The March of Dimes intends to invest $10 million ... March of Dimes Prematurity Research Center -- Ohio Collaborative ... Howse, President of the March of Dimes. "This new ...
Breaking Medicine News(10 mins):Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 2Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 3Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 2Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 3Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3
... -- A new three-year study finds that a multiple sclerosis drug ... form of MS if it,s given early in patients who appear ... called "interferon beta-1a," is not available in the United States. It ... elsewhere. "While we,ve known it,s beneficial to start MS drugs ...
... have discovered that salicylate, the active ingredient in aspirin, ... protein kinase), a key player in regulating cell growth ... fuel-gauge is switched on by exercise and the commonly ... at McMaster University, the University of Dundee and the ...
... HealthDay Reporter , THURSDAY, April 19 (HealthDay News) -- ... the chronic inflammatory skin disease known as psoriasis than ... researchers found that biologics, which can cost upwards of ... standard drug treatment for psoriasis, methotrexate, but that their ...
... , THURSDAY, April 19 (HealthDay News) -- Most ... of a cancer diagnosis low: Don,t smoke, eat healthy, exercise ... make those choices, and a new report suggests that lawmakers ... those changes easier ones to make. ...
... , THURSDAY, April 19 (HealthDay News) -- Online ... a small new study. This is because scammers not ... them by pretending to have a meaningful connection with them. ... was a significant relationship. The U.K. study included 11 ...
... Scientists have identified 33 genes associated with autism and related ... to be altered in people with schizophrenia. Of the ... the first time, according to the study, which currently appears ... print issue of the journal Cell . "By ...
Cached Medicine News:Health News:Early Use of MS Drug May Cut Likelihood of Progression 2Health News:McMaster researchers find potential for new uses of old drug 2Health News:New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds 2Health News:New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds 3Health News:Healthy Lifestyle Choices Could Cut Cancer Rates: Report 2Health News:Healthy Lifestyle Choices Could Cut Cancer Rates: Report 3Health News:Online Dating Scams Can Take Emotional, Financial Toll 2Health News:Genes Associated With Autism Also Related to Schizophrenia 2
(Date:5/21/2013)... 2013  Zacks.com announces the list of stocks featured ... Research analysts discuss the latest news and events impacting ... the blog include Actavis, Inc.,s (NYSE: ACT ), ... TOT ), Petrobras (NYSE: PBR ) and ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) Get the ...
(Date:5/21/2013)... 2013  IsoRay, Inc. (AMEX: ISR ), ... into an exclusive international distribution agreement with IASIS Medical ... Greece . IsoRay is a medical ... radioisotope applications for brain cancer, lung cancer, head and ... IASIS Medical is ideally suited to support ...
(Date:5/21/2013)... Hurel Corporation ("Hurel"), a world-leading provider of ... today announced the appointment of James S. ... of Directors. Dr. MacDonald is the former Executive Vice ... ("SPRI"), which was the pharmaceutical development arm of Schering ... in 2009. Over a career that has ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... Oct. 5, 2011 Reportlinker.com announces ... is available in its catalogue: ... Dermatological Drugs, 7th Edition ... This Kalorama Information report details the ...
... Calif., Oct. 5, 2011 In an independent study ... the University of Texas Health Science Center San Antonio ... to compromised blood flow during reconstructive microsurgery when compared ... study by Dr. Cornejo and colleagues is important as ...
Cached Medicine Technology:The Market for Prescription Dermatological Drugs, 7th Edition 2The Market for Prescription Dermatological Drugs, 7th Edition 3The Market for Prescription Dermatological Drugs, 7th Edition 4The Market for Prescription Dermatological Drugs, 7th Edition 5The Market for Prescription Dermatological Drugs, 7th Edition 6The Market for Prescription Dermatological Drugs, 7th Edition 7The Market for Prescription Dermatological Drugs, 7th Edition 8The Market for Prescription Dermatological Drugs, 7th Edition 9The Market for Prescription Dermatological Drugs, 7th Edition 10The Market for Prescription Dermatological Drugs, 7th Edition 11The Market for Prescription Dermatological Drugs, 7th Edition 12The Market for Prescription Dermatological Drugs, 7th Edition 13The Market for Prescription Dermatological Drugs, 7th Edition 14The Market for Prescription Dermatological Drugs, 7th Edition 15Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: